EMEA (Europe, Middle East and Africa) Adrenoleukodystrophy Drugs Market Report 2017

December 2017 | 109 pages | ID: E92EEF4EB19EN
QYResearch

Abstracts

In this report, the EMEA Adrenoleukodystrophy Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Adrenoleukodystrophy Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Adrenoleukodystrophy Drugs market competition by top manufacturers/players, with Adrenoleukodystrophy Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Applied Genetic Technologies Corp
• Bluebird Bio Inc
• MedDay SA
• Minoryx Therapeutics sl
• Pfizer Inc
• ReceptoPharm Inc
• SOM Biotech SL
• Viking Therapeutics Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Biotin
• DRX-065
• DUOC-01
• Lenti-D
• MIN-102
• OP-101
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Children
• Adult

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Adrenoleukodystrophy Drugs Market Report 2017

1 ADRENOLEUKODYSTROPHY DRUGS OVERVIEW

1.1 Product Overview and Scope of Adrenoleukodystrophy Drugs
1.2 Classification of Adrenoleukodystrophy Drugs
  1.2.1 EMEA Adrenoleukodystrophy Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Adrenoleukodystrophy Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Biotin
  1.2.4 DRX-065
  1.2.5 DUOC-01
  1.2.6 Lenti-D
  1.2.7 MIN-102
  1.2.8 OP-101
  1.2.9 Others
1.3 EMEA Adrenoleukodystrophy Drugs Market by Application/End Users
  1.3.1 EMEA Adrenoleukodystrophy Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Children
  1.3.3 Adult
1.4 EMEA Adrenoleukodystrophy Drugs Market by Region
  1.4.1 EMEA Adrenoleukodystrophy Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Adrenoleukodystrophy Drugs (2012-2022)
  1.5.1 EMEA Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2022)

2 EMEA ADRENOLEUKODYSTROPHY DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Adrenoleukodystrophy Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Adrenoleukodystrophy Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Adrenoleukodystrophy Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Adrenoleukodystrophy Drugs Sale Price by Players (2012-2017)
2.2 EMEA Adrenoleukodystrophy Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Adrenoleukodystrophy Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Adrenoleukodystrophy Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Adrenoleukodystrophy Drugs Sale Price by Type (2012-2017)
2.3 EMEA Adrenoleukodystrophy Drugs (Volume) by Application
2.4 EMEA Adrenoleukodystrophy Drugs (Volume and Value) by Region
  2.4.1 EMEA Adrenoleukodystrophy Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Adrenoleukodystrophy Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Adrenoleukodystrophy Drugs Sales Price by Region (2012-2017)

3 EUROPE ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  3.1.1 Europe Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Adrenoleukodystrophy Drugs Sales and Market Share by Type
3.3 Europe Adrenoleukodystrophy Drugs Sales and Market Share by Application
3.4 Europe Adrenoleukodystrophy Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Adrenoleukodystrophy Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Adrenoleukodystrophy Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Adrenoleukodystrophy Drugs Sales and Market Share by Type
4.3 Middle East Adrenoleukodystrophy Drugs Sales and Market Share by Application
4.4 Middle East Adrenoleukodystrophy Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Adrenoleukodystrophy Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Adrenoleukodystrophy Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)

5 AFRICA ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  5.1.1 Africa Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Adrenoleukodystrophy Drugs Sales and Market Share by Type
5.3 Africa Adrenoleukodystrophy Drugs Sales and Market Share by Application
5.4 Africa Adrenoleukodystrophy Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Adrenoleukodystrophy Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Adrenoleukodystrophy Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2017)

6 EMEA ADRENOLEUKODYSTROPHY DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Applied Genetic Technologies Corp
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Adrenoleukodystrophy Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bluebird Bio Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Adrenoleukodystrophy Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 MedDay SA
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Adrenoleukodystrophy Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 MedDay SA Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Minoryx Therapeutics sl
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Adrenoleukodystrophy Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Adrenoleukodystrophy Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 ReceptoPharm Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Adrenoleukodystrophy Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 SOM Biotech SL
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Adrenoleukodystrophy Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 SOM Biotech SL Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Viking Therapeutics Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Adrenoleukodystrophy Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ADRENOLEUKODYSTROPHY DRUGS MANUFACTURING COST ANALYSIS

7.1 Adrenoleukodystrophy Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Adrenoleukodystrophy Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Adrenoleukodystrophy Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Adrenoleukodystrophy Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ADRENOLEUKODYSTROPHY DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Adrenoleukodystrophy Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Adrenoleukodystrophy Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Adrenoleukodystrophy Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Adrenoleukodystrophy Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Adrenoleukodystrophy Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Adrenoleukodystrophy Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Adrenoleukodystrophy Drugs
Figure EMEA Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Biotin Product Picture
Figure DRX-065 Product Picture
Figure DUOC-01 Product Picture
Figure Lenti-D Product Picture
Figure MIN-102 Product Picture
Figure OP-101 Product Picture
Figure Others Product Picture
Figure EMEA Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Adrenoleukodystrophy Drugs by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adult Examples
Table Key Downstream Customer in Adult
Figure EMEA Adrenoleukodystrophy Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Adrenoleukodystrophy Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Adrenoleukodystrophy Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Adrenoleukodystrophy Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Adrenoleukodystrophy Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Sales Share by Players (2012-2017)
Figure 2016 Adrenoleukodystrophy Drugs Sales Share by Players
Figure 2017 Adrenoleukodystrophy Drugs Sales Share by Players
Figure EMEA Adrenoleukodystrophy Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Adrenoleukodystrophy Drugs Revenue Share by Players
Table 2017 EMEA Adrenoleukodystrophy Drugs Revenue Share by Players
Table EMEA Adrenoleukodystrophy Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Adrenoleukodystrophy Drugs by Type (2012-2017)
Figure EMEA Adrenoleukodystrophy Drugs Sales Market Share by Type (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Adrenoleukodystrophy Drugs by Type in 2016
Table EMEA Adrenoleukodystrophy Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Adrenoleukodystrophy Drugs by Application (2012-2017)
Figure EMEA Adrenoleukodystrophy Drugs Sales Market Share by Application in 2016
Table EMEA Adrenoleukodystrophy Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Adrenoleukodystrophy Drugs by Region (2012-2017)
Figure EMEA Adrenoleukodystrophy Drugs Sales Market Share in 2016
Table EMEA Adrenoleukodystrophy Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Adrenoleukodystrophy Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Adrenoleukodystrophy Drugs by Region (2012-2017)
Figure EMEA Adrenoleukodystrophy Drugs Revenue Market Share Regions in 2016
Table EMEA Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
Table Europe Adrenoleukodystrophy Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe Adrenoleukodystrophy Drugs Market Share by Type (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Market Share by Type in 2016
Table Europe Adrenoleukodystrophy Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe Adrenoleukodystrophy Drugs Market Share by Application (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Market Share by Application in 2016
Table Europe Adrenoleukodystrophy Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe Adrenoleukodystrophy Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Sales Market Share by Countries in 2016
Table Europe Adrenoleukodystrophy Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Adrenoleukodystrophy Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Adrenoleukodystrophy Drugs Revenue Market Share by Countries in 2016
Figure Germany Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Adrenoleukodystrophy Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East Adrenoleukodystrophy Drugs Market Share by Type (2012-2017)
Figure Middle East Adrenoleukodystrophy Drugs Market Share by Type (2012-2017)
Table Middle East Adrenoleukodystrophy Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East Adrenoleukodystrophy Drugs Market Share by Applications (2012-2017)
Figure Middle East Adrenoleukodystrophy Drugs Sales Market Share by Application in 2016
Table Middle East Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Adrenoleukodystrophy Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Adrenoleukodystrophy Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Adrenoleukodystrophy Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Adrenoleukodystrophy Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Adrenoleukodystrophy Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Adrenoleukodystrophy Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Adrenoleukodystrophy Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa Adrenoleukodystrophy Drugs Sales Market Share by Type (2012-2017)
Figure Africa Adrenoleukodystrophy Drugs Sales Market Share by Type (2012-2017)
Figure Africa Adrenoleukodystrophy Drugs Sales Market Share by Type in 2016
Table Africa Adrenoleukodystrophy Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa Adrenoleukodystrophy Drugs Sales Market Share by Application (2012-2017)
Figure Africa Adrenoleukodystrophy Drugs Sales Market Share by Application (2012-2017)
Table Africa Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Adrenoleukodystrophy Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Adrenoleukodystrophy Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Adrenoleukodystrophy Drugs Sales Market Share by Countries in 2016
Table Africa Adrenoleukodystrophy Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Adrenoleukodystrophy Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Adrenoleukodystrophy Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Adrenoleukodystrophy Drugs Revenue Market Share by Countries in 2016
Figure South Africa Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Basic Information List
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales Market Share in EMEA (2012-2017)
Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Revenue Market Share in EMEA (2012-2017)
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Basic Information List
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales Market Share in EMEA (2012-2017)
Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Revenue Market Share in EMEA (2012-2017)
Table MedDay SA Adrenoleukodystrophy Drugs Basic Information List
Table MedDay SA Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MedDay SA Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure MedDay SA Adrenoleukodystrophy Drugs Sales Market Share in EMEA (2012-2017)
Figure MedDay SA Adrenoleukodystrophy Drugs Revenue Market Share in EMEA (2012-2017)
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Basic Information List
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales Market Share in EMEA (2012-2017)
Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc Adrenoleukodystrophy Drugs Basic Information List
Table Pfizer Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Inc Adrenoleukodystrophy Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc Adrenoleukodystrophy Drugs Revenue Market Share in EMEA (2012-2017)
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Basic Information List
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales Market Share in EMEA (2012-2017)
Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Revenue Market Share in EMEA (2012-2017)
Table SOM Biotech SL Adrenoleukodystrophy Drugs Basic Information List
Table SOM Biotech SL Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure SOM Biotech SL Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure SOM Biotech SL Adrenoleukodystrophy Drugs Sales Market Share in EMEA (2012-2017)
Figure SOM Biotech SL Adrenoleukodystrophy Drugs Revenue Market Share in EMEA (2012-2017)
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Basic Information List
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales Market Share in EMEA (2012-2017)
Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adrenoleukodystrophy Drugs
Figure Manufacturing Process Analysis of Adrenoleukodystrophy Drugs
Figure Adrenoleukodystrophy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Adrenoleukodystrophy Drugs Major Manufacturers in 2016
Table Major Buyers of Adrenoleukodystrophy Drugs
Table Distributors/Traders List
Figure EMEA Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Adrenoleukodystrophy Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Adrenoleukodystrophy Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Adrenoleukodystrophy Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Adrenoleukodystrophy Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Adrenoleukodystrophy Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Adrenoleukodystrophy Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Adrenoleukodystrophy Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Adrenoleukodystrophy Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Adrenoleukodystrophy Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Adrenoleukodystrophy Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Adrenoleukodystrophy Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Adrenoleukodystrophy Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Adrenoleukodystrophy Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Adrenoleukodystrophy Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Adrenoleukodystrophy Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Adrenoleukodystrophy Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Adrenoleukodystrophy Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Adrenoleukodystrophy Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Adrenoleukodystrophy Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Adrenoleukodystrophy Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Adrenoleukodystrophy Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Adrenoleukodystrophy Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources